cigna glp-1 will stop covering weight-loss drugs including Wegovy and Zepbound in its employee health plan effective July 1, according to Reuters #duet with @ladyspinedoc 😮18 million
Description
According to the Real Chemistry study, lower-income individuals are more likely to be obese, yet higher-income patients are the primary users of these medications due to their ability to pay out of pocket
Consistency matters more than clock position

What Is GIP and How Is It Different

[DOI] [Google Scholar] 122.Mller T.D., Finan B., Clemmensen C., DiMarchi R.D., Tschp M.H

We vet everything on PubMed so you dont have to
It is a state-of-the-art system that solves not only todays but also the challenges of tomorrow
